▶ 調査レポート

世界の過活動膀胱薬市場：市場規模・現状・予測
• 英文タイトル：Global Overactive Bladder Drug Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の過活動膀胱薬市場：市場規模・現状・予測 / Global Overactive Bladder Drug Market Size, Status and Forecast 2019-2025 / QYR9N7749資料のイメージです。• レポートコード：QYR9N7749
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、過活動膀胱薬のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・過活動膀胱薬の世界市場規模
・主要企業別市場シェア
・過活動膀胱薬の世界市場規模：種類別（）
・過活動膀胱薬の世界市場規模：用途別（）
・過活動膀胱薬のアメリカ市場規模（種類別、用途別）
・過活動膀胱薬のヨーロッパ市場規模（種類別、用途別）
・過活動膀胱薬の中国市場規模（種類別、用途別）
・過活動膀胱薬の日本市場規模（種類別、用途別）
・過活動膀胱薬の東南アジア市場規模（種類別、用途別）
・過活動膀胱薬のインド市場規模（種類別、用途別）
・過活動膀胱薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・過活動膀胱薬の世界市場予測（2019年-2025年）
・過活動膀胱薬の地域別市場予測（2019年-2025年）
...

In 2018, the global Overactive Bladder Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Overactive Bladder Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Overactive Bladder Drug development in United States, Europe and China.

The key players covered in this study
Astellas Pharma, Inc. (Japan)
Pfizer, Inc. (U.S.)
Teva Pharmaceutical Industries Limited (Israel)
Allergan, Plc (Ireland)
Medtronic plc (Ireland)
Mylan N.V. (U.S.)
Endo International plc (Ireland)
Hisamitsu Pharmaceutical Co., Inc. (Japan)
Sanofi (France)
Apotex, Inc. (Canada)
Cogentix Medical, Inc. (U.S.)
Aurobindo Pharma Limited (India)

Market segment by Type, the product can be split into
Anticholinergics
Solifenacin
Oxybutynin
Darifenacin
Fesoterodine
Tolterodine
Trospium
Others

Market segment by Application, split into
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Overactive Bladder Drug status, future forecast, growth opportunity, key market and key players.
To present the Overactive Bladder Drug development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Overactive Bladder Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Overactive Bladder Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Anticholinergics
1.4.3 Solifenacin
1.4.4 Oxybutynin
1.4.5 Darifenacin
1.4.6 Fesoterodine
1.4.7 Tolterodine
1.4.8 Trospium
1.4.9 Others
1.5 Market by Application
1.5.1 Global Overactive Bladder Drug Market Share by Application (2014-2025)
1.5.2 Idiopathic Bladder Overactivity
1.5.3 Neurogenic Bladder Overactivity
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Overactive Bladder Drug Market Size
2.2 Overactive Bladder Drug Growth Trends by Regions
2.2.1 Overactive Bladder Drug Market Size by Regions (2014-2025)
2.2.2 Overactive Bladder Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Overactive Bladder Drug Market Size by Manufacturers
3.1.1 Global Overactive Bladder Drug Revenue by Manufacturers (2014-2019)
3.1.2 Global Overactive Bladder Drug Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Overactive Bladder Drug Market Concentration Ratio (CR5 and HHI)
3.2 Overactive Bladder Drug Key Players Head office and Area Served
3.3 Key Players Overactive Bladder Drug Product/Solution/Service
3.4 Date of Enter into Overactive Bladder Drug Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Overactive Bladder Drug Market Size by Type (2014-2019)
4.2 Global Overactive Bladder Drug Market Size by Application (2014-2019)

5 United States
5.1 United States Overactive Bladder Drug Market Size (2014-2019)
5.2 Overactive Bladder Drug Key Players in United States
5.3 United States Overactive Bladder Drug Market Size by Type
5.4 United States Overactive Bladder Drug Market Size by Application

6 Europe
6.1 Europe Overactive Bladder Drug Market Size (2014-2019)
6.2 Overactive Bladder Drug Key Players in Europe
6.3 Europe Overactive Bladder Drug Market Size by Type
6.4 Europe Overactive Bladder Drug Market Size by Application

7 China
7.1 China Overactive Bladder Drug Market Size (2014-2019)
7.2 Overactive Bladder Drug Key Players in China
7.3 China Overactive Bladder Drug Market Size by Type
7.4 China Overactive Bladder Drug Market Size by Application

8 Japan
8.1 Japan Overactive Bladder Drug Market Size (2014-2019)
8.2 Overactive Bladder Drug Key Players in Japan
8.3 Japan Overactive Bladder Drug Market Size by Type
8.4 Japan Overactive Bladder Drug Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Overactive Bladder Drug Market Size (2014-2019)
9.2 Overactive Bladder Drug Key Players in Southeast Asia
9.3 Southeast Asia Overactive Bladder Drug Market Size by Type
9.4 Southeast Asia Overactive Bladder Drug Market Size by Application

10 India
10.1 India Overactive Bladder Drug Market Size (2014-2019)
10.2 Overactive Bladder Drug Key Players in India
10.3 India Overactive Bladder Drug Market Size by Type
10.4 India Overactive Bladder Drug Market Size by Application

11 Central & South America
11.1 Central & South America Overactive Bladder Drug Market Size (2014-2019)
11.2 Overactive Bladder Drug Key Players in Central & South America
11.3 Central & South America Overactive Bladder Drug Market Size by Type
11.4 Central & South America Overactive Bladder Drug Market Size by Application

12 International Players Profiles
12.1 Astellas Pharma, Inc. (Japan)
12.1.1 Astellas Pharma, Inc. (Japan) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Overactive Bladder Drug Introduction
12.1.4 Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Drug Business (2014-2019)
12.1.5 Astellas Pharma, Inc. (Japan) Recent Development
12.2 Pfizer, Inc. (U.S.)
12.2.1 Pfizer, Inc. (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Overactive Bladder Drug Introduction
12.2.4 Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Drug Business (2014-2019)
12.2.5 Pfizer, Inc. (U.S.) Recent Development
12.3 Teva Pharmaceutical Industries Limited (Israel)
12.3.1 Teva Pharmaceutical Industries Limited (Israel) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Overactive Bladder Drug Introduction
12.3.4 Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Drug Business (2014-2019)
12.3.5 Teva Pharmaceutical Industries Limited (Israel) Recent Development
12.4 Allergan, Plc (Ireland)
12.4.1 Allergan, Plc (Ireland) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Overactive Bladder Drug Introduction
12.4.4 Allergan, Plc (Ireland) Revenue in Overactive Bladder Drug Business (2014-2019)
12.4.5 Allergan, Plc (Ireland) Recent Development
12.5 Medtronic plc (Ireland)
12.5.1 Medtronic plc (Ireland) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Overactive Bladder Drug Introduction
12.5.4 Medtronic plc (Ireland) Revenue in Overactive Bladder Drug Business (2014-2019)
12.5.5 Medtronic plc (Ireland) Recent Development
12.6 Mylan N.V. (U.S.)
12.6.1 Mylan N.V. (U.S.) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Overactive Bladder Drug Introduction
12.6.4 Mylan N.V. (U.S.) Revenue in Overactive Bladder Drug Business (2014-2019)
12.6.5 Mylan N.V. (U.S.) Recent Development
12.7 Endo International plc (Ireland)
12.7.1 Endo International plc (Ireland) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Overactive Bladder Drug Introduction
12.7.4 Endo International plc (Ireland) Revenue in Overactive Bladder Drug Business (2014-2019)
12.7.5 Endo International plc (Ireland) Recent Development
12.8 Hisamitsu Pharmaceutical Co., Inc. (Japan)
12.8.1 Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Overactive Bladder Drug Introduction
12.8.4 Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Drug Business (2014-2019)
12.8.5 Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development
12.9 Sanofi (France)
12.9.1 Sanofi (France) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Overactive Bladder Drug Introduction
12.9.4 Sanofi (France) Revenue in Overactive Bladder Drug Business (2014-2019)
12.9.5 Sanofi (France) Recent Development
12.10 Apotex, Inc. (Canada)
12.10.1 Apotex, Inc. (Canada) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Overactive Bladder Drug Introduction
12.10.4 Apotex, Inc. (Canada) Revenue in Overactive Bladder Drug Business (2014-2019)
12.10.5 Apotex, Inc. (Canada) Recent Development
12.11 Cogentix Medical, Inc. (U.S.)
12.12 Aurobindo Pharma Limited (India)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Overactive Bladder Drug Key Market Segments
Table Key Players Overactive Bladder Drug Covered
Table Global Overactive Bladder Drug Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Overactive Bladder Drug Market Size Market Share by Type 2014-2025
Figure Anticholinergics Figures
Table Key Players of Anticholinergics
Figure Solifenacin Figures
Table Key Players of Solifenacin
Figure Oxybutynin Figures
Table Key Players of Oxybutynin
Figure Darifenacin Figures
Table Key Players of Darifenacin
Figure Fesoterodine Figures
Table Key Players of Fesoterodine
Figure Tolterodine Figures
Table Key Players of Tolterodine
Figure Trospium Figures
Table Key Players of Trospium
Figure Others Figures
Table Key Players of Others
Table Global Overactive Bladder Drug Market Size Growth by Application 2014-2025 (Million US$)
Figure Idiopathic Bladder Overactivity Case Studies
Figure Neurogenic Bladder Overactivity Case Studies
Figure Overactive Bladder Drug Report Years Considered
Table Global Overactive Bladder Drug Market Size 2014-2025 (Million US$)
Figure Global Overactive Bladder Drug Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Overactive Bladder Drug Market Size by Regions 2014-2025 (Million US$)
Table Global Overactive Bladder Drug Market Size by Regions 2014-2019 (Million US$)
Table Global Overactive Bladder Drug Market Share by Regions 2014-2019
Figure Global Overactive Bladder Drug Market Share by Regions 2014-2019
Figure Global Overactive Bladder Drug Market Share by Regions 2019
Table Market Top Trends
Table Global Overactive Bladder Drug Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Overactive Bladder Drug Market Share by Manufacturers (2014-2019)
Figure Global Overactive Bladder Drug Market Share by Manufacturers in 2018
Table Global Overactive Bladder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Overactive Bladder Drug Product/Solution/Service
Table Date of Enter into Overactive Bladder Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Overactive Bladder Drug Market Size by Type (2014-2019) (Million US$)
Table Global Overactive Bladder Drug Market Size Share by Type (2014-2019)
Figure Global Overactive Bladder Drug Market Size Market Share by Type (2014-2019)
Table Global Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table Global Overactive Bladder Drug Market Size Share by Application (2014-2019)
Figure Global Overactive Bladder Drug Market Size Market Share by Application (2014-2019)
Figure Global Overactive Bladder Drug Revenue Market Share by Application in 2018
Figure United States Overactive Bladder Drug Market Size 2014-2019 (Million US$)
Table United States Key Players Overactive Bladder Drug Revenue (2018-2019) (Million US$)
Table United States Key Players Overactive Bladder Drug Market Share (2018-2019)
Table United States Overactive Bladder Drug Market Size by Type (2014-2019) (Million US$)
Table United States Overactive Bladder Drug Market Share by Type (2014-2019)
Table United States Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table United States Overactive Bladder Drug Market Share by Application (2014-2019)
Figure Europe Overactive Bladder Drug Market Size 2014-2019 (Million US$)
Table Europe Key Players Overactive Bladder Drug Revenue (2018-2019) (Million US$)
Table Europe Key Players Overactive Bladder Drug Market Share (2018-2019)
Table Europe Overactive Bladder Drug Market Size by Type (2014-2019) (Million US$)
Table Europe Overactive Bladder Drug Market Share by Type (2014-2019)
Table Europe Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table Europe Overactive Bladder Drug Market Share by Application (2014-2019)
Figure China Overactive Bladder Drug Market Size 2014-2019 (Million US$)
Table China Key Players Overactive Bladder Drug Revenue (2018-2019) (Million US$)
Table China Key Players Overactive Bladder Drug Market Share (2018-2019)
Table China Overactive Bladder Drug Market Size by Type (2014-20189) (Million US$)
Table China Overactive Bladder Drug Market Share by Type (2014-2019)
Table China Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table China Overactive Bladder Drug Market Share by Application (2014-2019)
Figure Japan Overactive Bladder Drug Market Size 2014-2019 (Million US$)
Table Japan Key Players Overactive Bladder Drug Revenue (2018-2019) (Million US$)
Table Japan Key Players Overactive Bladder Drug Market Share (2018-2019)
Table Japan Overactive Bladder Drug Market Size by Type (2014-2019) (Million US$)
Table Japan Overactive Bladder Drug Market Share by Type (2014-2019)
Table Japan Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table Japan Overactive Bladder Drug Market Share by Application (2014-2019)
Figure Southeast Asia Overactive Bladder Drug Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Overactive Bladder Drug Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Overactive Bladder Drug Market Share (2018-2019)
Table Southeast Asia Overactive Bladder Drug Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Overactive Bladder Drug Market Share by Type (2014-2019)
Table Southeast Asia Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Overactive Bladder Drug Market Share by Application (2014-2019)
Figure India Overactive Bladder Drug Market Size 2014-2019 (Million US$)
Table India Key Players Overactive Bladder Drug Revenue (2018-2019) (Million US$)
Table India Key Players Overactive Bladder Drug Market Share (2018-2019)
Table India Overactive Bladder Drug Market Size by Type (2014-2019) (Million US$)
Table India Overactive Bladder Drug Market Share by Type (2014-2019)
Table India Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table India Overactive Bladder Drug Market Share by Application (2014-2019)
Figure Central & South America Overactive Bladder Drug Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Overactive Bladder Drug Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Overactive Bladder Drug Market Share (2018-2019)
Table Central & South America Overactive Bladder Drug Market Size by Type (2014-2019) (Million US$)
Table Central & South America Overactive Bladder Drug Market Share by Type (2014-2019)
Table Central & South America Overactive Bladder Drug Market Size by Application (2014-2019) (Million US$)
Table Central & South America Overactive Bladder Drug Market Share by Application (2014-2019)
Table Astellas Pharma, Inc. (Japan) Company Details
Table Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Drug Business (2014-2019) (Million US$)
Figure Astellas Pharma, Inc. (Japan) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Astellas Pharma, Inc. (Japan) Recent Development
Table Pfizer, Inc. (U.S.) Company Details
Table Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Pfizer, Inc. (U.S.) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Pfizer, Inc. (U.S.) Recent Development
Table Teva Pharmaceutical Industries Limited (Israel) Company Details
Table Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Limited (Israel) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Teva Pharmaceutical Industries Limited (Israel) Recent Development
Table Allergan, Plc (Ireland) Company Details
Table Allergan, Plc (Ireland) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Allergan, Plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Allergan, Plc (Ireland) Recent Development
Table Medtronic plc (Ireland) Company Details
Table Medtronic plc (Ireland) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Medtronic plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Medtronic plc (Ireland) Recent Development
Table Mylan N.V. (U.S.) Company Details
Table Mylan N.V. (U.S.) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Mylan N.V. (U.S.) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Mylan N.V. (U.S.) Recent Development
Table Endo International plc (Ireland) Company Details
Table Endo International plc (Ireland) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Endo International plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Endo International plc (Ireland) Recent Development
Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details
Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development
Table Sanofi (France) Company Details
Table Sanofi (France) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Sanofi (France) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Sanofi (France) Recent Development
Table Apotex, Inc. (Canada) Company Details
Table Apotex, Inc. (Canada) Revenue in Overactive Bladder Drug Business (2014-2019)(Million US$)
Figure Apotex, Inc. (Canada) Revenue Growth Rate in Overactive Bladder Drug Business (2014-2019)
Table Apotex, Inc. (Canada) Recent Development
Table Cogentix Medical, Inc. (U.S.) Company Details
Table Aurobindo Pharma Limited (India) Company Details
Table Global Overactive Bladder Drug Market Size by Regions (Million US$) 2019-2025
Figure Global Overactive Bladder Drug Market Size Share by Regions (2019-2025)
Figure Global Overactive Bladder Drug Market Size Share by Regions in 2025
Figure United States Overactive Bladder Drug Market Size Forecast (2019-2025)(Million USD)
Figure Europe Overactive Bladder Drug Market Size Forecast (2019-2025)(Million USD)
Figure China Overactive Bladder Drug Market Size Forecast (2019-2025)(Million USD)
Figure Japan Overactive Bladder Drug Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Overactive Bladder Drug Market Size Forecast (2019-2025)(Million USD)
Figure India Overactive Bladder Drug Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Overactive Bladder Drug Market Size Forecast (2019-2025)(Million USD)
Table Global Overactive Bladder Drug Market Size by Product (2019-2025) (Million US$)
Figure Global Overactive Bladder Drug Market Size by Product (2019-2025)
Figure Global Overactive Bladder Drug Market Size by Product in 2025
Table Global Overactive Bladder Drug Market Size by Application (2019-2025) (Million US$)
Figure Global Overactive Bladder Drug Market Size by Application (2019-2025)
Figure Global Overactive Bladder Drug Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の過活動膀胱治療学市場：市場規模・現状・予測
    Global Overactive Bladder Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7750 2019年6月14日 92Pages
    当資料は、過活動膀胱治療学のグローバル市場について調査・分析したレポートで、種類別（抗コリン作用薬、ミラベグロン、ボトックス）、用途別（特発性過活動膀胱、神経性過活動膀胱）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界のスニチニブ薬市場：市場規模・現状・予測
    Global Sunitinib Drug Market Size, Status and Forecast 2019-2025
    QYR9N8092 2019年6月14日 92Pages
    当資料は、スニチニブ薬のグローバル市場について調査・分析したレポートで、種類別（12.5 mgのカプセル、25 mgカプセル、37.5 mgカプセル、50 mgカプセル）、用途別（腎臓がん、GIST、pNET）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...
  • 世界のデシタビン薬市場：市場規模・現状・予測
    Global Decitabine Drug Market Size, Status and Forecast 2019-2025
    QYR9N7070 2019年6月14日 95Pages
    当資料は、デシタビン薬のグローバル市場について調査・分析したレポートで、種類別（ダコゲン、ジェネリック）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・デ...
  • 世界のハイドレーションブラダー市場2019
    Global Hydration Bladder Sales Market Report 2019
    QYR9N1742 2019年6月10日 103Pages
    本調査レポートでは、ハイドレーションブラダーの世界市場について調査・分析し、ハイドレーションブラダーのメーカー別販売量、市場シェア分析、種類別販売分析（プラスチック、合成）、用途別販売分析（旅行、軍事、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、...
  • 世界のシクロベンザプリン薬市場：市場規模・現状・予測
    Global Cyclobenzaprine Drug Market Size, Status and Forecast 2019-2025
    QYR9N7055 2019年6月14日 94Pages
    当資料は、シクロベンザプリン薬のグローバル市場について調査・分析したレポートで、種類別（タブレット、カプセル）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ...
  • 世界の鎮痛剤デリバリー市場：市場規模・現状・予測
    Global Pain Drug Delivery Market Size, Status and Forecast 2019-2025
    QYR9N7754 2019年6月14日 94Pages
    当資料は、鎮痛剤デリバリーのグローバル市場について調査・分析したレポートで、種類別（経皮ドラッグデリバリーシステム、髄腔内ドラッグデリバリーシステム、その他）、用途別（腫瘍学、神経学的障害、肺疾患、ホルモン障害、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...
  • 世界の外注創薬市場：市場規模・現状・予測
    Global Outsourced Drug Discovery Market Size, Status and Forecast 2019-2025
    QYR9N7744 2019年6月14日 95Pages
    当資料は、外注創薬のグローバル市場について調査・分析したレポートで、種類別（化学サービス、生物学的サービス、リード最適化、リード識別とスクリーニング）、用途別（製薬会社、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...
  • 世界のレボセチリジン薬市場：市場規模・現状・予測
    Global Levocetirizine Drug Market Size, Status and Forecast 2019-2025
    QYR9N7449 2019年6月14日 97Pages
    当資料は、レボセチリジン薬のグローバル市場について調査・分析したレポートで、種類別（錠剤、経口液）、用途別（65歳以上、12〜64歳、6〜11歳、2〜5歳）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の3D超音波ブラダースキャナー市場2019
    Global 3D Ultrasound Bladder Scanners Sales Market Report 2019
    QYR9N5966 2019年6月14日 102Pages
    本調査レポートでは、3D超音波ブラダースキャナーの世界市場について調査・分析し、3D超音波ブラダースキャナーのメーカー別販売量、市場シェア分析、種類別販売分析（精度：±10％以下、精度：±10％ - ±15％、精度：±15％以上）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨーロ...
  • 世界のチゲサイクリン薬市場：市場規模・現状・予測
    Global Tigecycline Drug Market Size, Status and Forecast 2019-2025
    QYR9N8124 2019年6月14日 93Pages
    当資料は、チゲサイクリン薬のグローバル市場について調査・分析したレポートで、種類別（TYGACIL、ジェネリック）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界の過活動膀胱治療学市場：市場規模・現状・予測世界の過活動膀胱治療学市場：市場規模・現状・予測 Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).North America is the largest consumption market of Overactive B…
  • 世界のハイドレーションブラダー市場2019世界のハイドレーションブラダー市場2019 The global Hydration Bladder market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Hydration Bladder market status and forecast, categorizes the global Hydration Bladder market size (value & volum…
  • 世界の3D超音波ブラダースキャナー市場2019世界の3D超音波ブラダースキャナー市場2019 The global 3D Ultrasound Bladder Scanners market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global 3D Ultrasound Bladder Scanners market status and forecast, categorizes the global 3D Ultrasound Blad…
  • ポータブル超音波ブラダースキャナーの世界市場予測 2024年：メーカー別、地域別、種類・用途別ポータブル超音波ブラダースキャナーの世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Portable Ultrasound Bladder Scanner is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Portable Ultr…
  • 世界のダリフェナシンHBr市場2019世界のダリフェナシンHBr市場2019 The global Darifenacin HBr market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Darifenacin HBr market status and forecast, categorizes the global Darifenacin HBr market size (value & volume) by …